Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quaker Chemical (KWR) Cash & Equivalents (2016 - 2026)

Quaker Chemical (KWR) has disclosed Cash & Equivalents for 17 consecutive years, with $169.7 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 8.86% year-over-year to $169.7 million; the TTM value through Mar 2026 reached $169.7 million, down 8.86%, while the annual FY2025 figure was $179.8 million, 4.79% down from the prior year.
  • Cash & Equivalents hit $169.7 million in Q1 2026 for Quaker Chemical, down from $179.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $212.1 million in Q3 2024 and bottomed at $138.9 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $185.3 million, with a median of $188.9 million recorded in 2024.
  • Year-over-year, Cash & Equivalents surged 42.82% in 2023 and then decreased 18.88% in 2025.
  • Quaker Chemical's Cash & Equivalents stood at $181.0 million in 2022, then grew by 7.5% to $194.5 million in 2023, then decreased by 2.9% to $188.9 million in 2024, then dropped by 4.79% to $179.8 million in 2025, then decreased by 5.62% to $169.7 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $169.7 million, $179.8 million, and $172.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.